The vertebrate inner ear arises from the otic placode, a transient thickening of ectodermal epithelium adjacent to neural crest domains in the presumptive head. During late gastrulation, cells fated to comprise the inner ear are part of a domain in cranial ectoderm that contain precursors of all sensory placodes, termed the preplacodal region (PPR). The combination of low levels of BMP activity coupled with high levels of FGF signaling are required to establish the PPR through induction of members of the six/eya/dach, iro, and dlx families of transcription factors. The zebrafish dlx3b/4b transcription factors are expressed at the neural plate border where they play partially redundant roles in the specification of the PPR, otic and olfactory placodes. We demonstrate that dlx3b/4b assist in establishing the PPR through the transcriptional regulation of the BMP antagonist cv2. Morpholinomediated knockdown of Dlx3b/4b results in loss of cv2 expression in the PPR and a transient increase in Bmp4 activity that lasts throughout early somitogenesis. Through the cv2-mediated inhibition of BMP activity, dlx3b/4b create an environment where FGF activity is favorable for PPR and otic marker expression. Our results provide insight into the mechanisms of PPR specification as well as the role of dlx3b/4b function in PPR and otic placode induction.
(Dlx) families of transcription factors during late gastrulation, which are the earliest markers of PPR fate (Ahrens and Schlosser, 2005; Brugmann et al., 2004; Glavic et al., 2004; Litsiou et al., 2005; Nguyen et al., 1998) . In particular, modulation of BMP activity at the neural plate border is instrumental in the establishment of the PPR and also patterns adjacent Rohon-Beard and neural crest domains (Nguyen et al., 1998; Nguyen et al., 2000; Rossi et al., 2008; Tribulo et al., 2003) .
In Xenopus and zebrafish, a BMP gradient model has been proposed in which BMP activity is high in ventral/lateral regions and progressively lower in more dorsal/medial regions during gastrulation. High levels of BMP activity are required to induce epidermis, low levels are required to specify neural plate, and intermediate levels are required to specify neural crest and Rohon-Beard domains (Aybar and Mayor, 2002; Nguyen et al., 1998; Nguyen et al., 2000; Tribulo et al., 2003) . Although the PPR lies lateral to the domain of neural crest, evidence from Xenopus, zebrafish and chick suggests that BMP activity must be lower in the PPR than in adjacent neural crest and epidermal territories (Ahrens and Schlosser, 2005; Glavic et al., 2004; Litsiou et al., 2005) . For example, implantation of Bmp4-containing beads near the PPR is sufficient to inhibit expression of the PPR marker Six1 (Ahrens and Schlosser, 2005) . Thus, it appears that establishment of the PPR requires lower levels of BMP activity than that required for neural crest and Rohon-Beard formation, contradictory to a simple gradient model.
While it is apparent that attenuation of BMP activity is critical in establishing the PPR, it is not yet clear how this attenuation is achieved. Tissue grafting experiments have revealed that potential BMP antagonists originate from tissues other than the PPR. Grafting of chicken head mesoderm onto extraembryonic ectoderm yields host tissue with PPR characteristics (Litsiou et al., 2005) . Likewise, transplantation of neural ectoderm into domains of ventral ectoderm yields similar results in Xenopus, demonstrating the role these tisues have in creating an environment suitable for the formation of the PPR (Ahrens and Schlosser, 2005) . However, the BMP antagonists involved in this process remain unidentified.
Members of the Dlx family of transcription factors are thought to play intrinsic roles in the formation of the PPR, although the mechanisms by which they do so are unclear. Dlx genes are required but not always sufficient for the expression of PPR markers from the Eya/Six/ Dach families. For example, ectopic expression of Six1 in Xenopus and chick can only be achieved in the presence of functional Dlx3 and Dlx5, respectively (Woda et al., 2003) . In zebrafish, dlx3b/4b are initially expressed along the entire neural plate border, which includes the PPR, at the end of gastrulation. Expression becomes restricted to the otic and olfactory placodes during somitogenesis (Ekker et al., 1992; Feledy et al., 1999; Pera et al., 1999) . Only rudimentary otic and olfactory placodes form when dlx3b/4b function is lost, and the resulting size of these sensory organs is significantly reduced (reviewed in Ohyama et al., 2007; reviewed in Riley, 2003) . Induction of early otic and olfactory markers, such as pax2a and eya1, is severely compromised, suggesting that dlx3b/4b function early in the process of otic and olfactory induction. Thus, it has been suggested that Dlx genes may act as competence factors for placode induction (Hans et al., 2007; Hans et al., 2004) .
In amniotes, Dlx5 and Dlx6 are expressed in a similar pattern to dlx3b/4b in zebrafish (Acampora et al., 1999; Yang et al., 1998) . However, inactivation of Dlx5/6 in mouse does not appear to affect induction of the otic or olfactory placodes, but rather their subsequent development (Merlo et al., 2002; Robledo and Lufkin, 2006; Robledo et al., 2002) . The reason for the discrepancy in phenotypes between zebrafish and mouse embryos lacking these Dlx paralogues is currently unclear.
To better understand the role of dlx3b/4b during the establishment of the PPR and otic placodes, we examined signaling activities involved in PPR and otic placode induction. We have identified that a BMP signaling modulator, Cv2, is critical for the formation of the PPR. The predominant function of this protein is as a BMP antagonist, although its proteolytic cleavage may allow Cv2 to act as an agonist of BMP activity (Rentzsch et al., 2006; Zhang et al., 2007; Zhang et al., 2008) . We show that cv2 lies transcriptionally downstream of dlx3b/4b, and that the full-length protein is required to modulate BMP activity to levels conducive for PPR formation. Morpholino-mediated knockdown of Dlx3b/4b results in loss of cv2 expression in the PPR and a transient increase in Bmp4 activity that is first observed at the end of gastrulation. This is followed by a transient decrease in FGF activity that can be rescued when cv2 or fgf-receptor 1 (fgfr1) mRNA is supplied in Dlx3b/4b morphants. Ectopic expression of either dlx3b or cv2 is sufficient to drive PPR marker expression. Conversely, loss of cv2 has similar effects on PPR development as loss of dlx3b/4b, indicating that a significant aspect of dlx3b/4b function at the end of gastrulation is mediated through cv2. Our results suggest a model in which dlx3b/4b-mediated modulation of BMP signaling through cv2 lies upstream of Six/Eya/Dach genes and FGF responsiveness in the specification of the PPR and induction of the otic placode. Furthermore, our findings provide a possible explanation for the difference in function of the Dlx genes between mouse and zebrafish.
Materials and Methods

Animals
Wild-type (AB) mutant zebrafish were obtained from the Zebrafish International Resource Center (Eugene, OR). Embryos were maintained at 28.5°C and staged using standard criteria (Kimmel et al., 1995) . Tg(hsp70l:dnBmpr-GFP) w30 (tBR) transgenic zebrafish were obtained from the Kimelman lab (University of Washington, Seattle). This transgenic line contains a truncated Type I Bmp receptor containing GFP in place of the kinase domain under the control of a heat-shock promoter (Pyati et al., 2005) . tBR embryos were heat shocked at 37°C for one hour at bud stage according to Pyati et al. (2005) . They were then sorted according to GFP expression and raised at 28.5°C until fixation. Where appropriate, wild-type or control morpholino-injected embryos were heat-shocked at the same stage as controls.
In situ hybridization
The following probes were used: bmp4 (Nikaido et al., 1997) , chordin (Miller-Bertoglio et al., 1997) , cv2 (Rentzsch et al., 2006) , dlx3b (Ekker et al., 1992) , erm (Raible and Brand, 2001) , eya1 (Sahly et al., 1999) , fgfr1 (Scholpp et al., 2004) , fgfr2 (Poss et al., 2000) , fgfr3 (Sleptsova-Friedrich et al., 2001) , fgfr4 (Thisse et al., 1995) , pax2a (Krauss et al., 1991) , six4.1 (Kobayashi et al., 2000) , spry4 (Fürthauer et al., 2001) , and tbx2b (Dheen et al., 1999) .
Real-time quantitative RT-PCR
RNA was isolated from three sets of 20 embryos of each experimental sample using the RNeasy kit (Qiagen). The SYBR Green I (Roche Applied Science) RNA amplification kit was used on the LightCycler according to the manufacturer's instructions and published protocols (Rajeevan et al., 2001) . The primers used for each of the genes were: bmp4 5'-AGCCAACACCGTGAGAGGATTC -3' and 5'-TCTGCGGTGGATATGAGTTCGTC -3'; fgfr1 5'-GCGGCTCCCCAATGCTCTCAG -3' and 5'-ATCGCCTCGGCCATCATCACC -3'; fgfr2 5'-CACATCAACGGCGGCATAAAAACAT -3' and 5'-TCGGGATCTGATTGGGAAGTAAC -3'; fgfr3 5'-GTGGCGGGAGTCGGGGATACAG -3' and 5'-ATTGATGATGCGGAGGGCTTTCT -3'; fgfr4 5'-CAATCAGGGTCATAAGGCAGTTCA -3' and 5'-GCAGCGCCAGAGGGAACGAAC -3'; ef1α 5'-GTACTACTCTTCTTATGCCC -3' and 5'-GTACAGTTCCAATACCTCCA -3'. The different samples were standardized using EF-1α transcript levels as a reference. Each experimental run was also performed in triplicate. Transcript levels were compared by oneway ANOVA, followed by a two-tailed, equal variance t-test.
Morpholino injection
Morpholino injections against bmp4 (Chocron et al., 2007) , chordin (Nasevicius and Ekker, 2000) , cv2 (mo1 sequence was used; Rentzsch et al., 2006) and dlx3b/4b (Solomon and Fritz, 2002) have been previously characterized. The control morpholino sequence was 5'-CCTCTTACCTCAGTTACAATTTATA -3'. For interaction analyses, chd mo concentration was chosen that elicited a V1 ventralization phenotype, approximately 2.5ng Mullins et al., 1996) . dlx3b/4b mo concentration was chosen that elicited a mild otic phenotype, approximately 5ng each.
mRNA synthesis
Capped mRNAs were transcribed using T7 and SP6 RNA polymerase in vitro transcription kits (mMESSAGE mMACHINE; Ambion). fgfr1 cDNA was amplified using the following primers: 5'-TTTGATAATAATAATGAAGATGATGATGATAAT -3' and 5'-ATGACGGATGTATTTGAGTTTTGAGA-3'. It was then cloned into pCRII-TOPO, digested with SpeI and XhoI and ligated into pCS2+ digested with XbaI and XhoI. The vector was linearized with ApaI and mRNA was synthesized using SP6 polymerase. For rescue of the Dlx3b/4b morphant phenotype, approximately 15pg mRNA was co-injected into one-and twocell embryos with dlx3b/4b MOs. bmp2b, bmp4, dlx3b, cv2, and cv2-N mRNA were synthesized and injected as previously described Rentzsch et al., 2006; Solomon and Fritz, 2002; Szeto and Kimelman, 2004) .
Antibody staining
Labeling with PSMAD1/5/8 was as previously described (Rentzsch et al., 2006) . The primary antibody was used at a dilution of 1:100 (anti-P SMAD1/5/8; Chemicon International). Secondary antibody was Alexa Fluor 594 goat anti-rabbit IgG at 1:500 (Molecular Probes).
Results
dlx3b/4b transiently regulate BMP activity
In Xenopus and chick, ectopic expression of BMP antagonists can induce ectopic PPR marker expression, while exposure to increased amounts of Bmp4 can ablate ectopic expression and reduce endogenous expression of the PPR markers Six1/4 and Eya2 (Ahrens and Schlosser, 2005; Brugmann et al., 2004; Litsiou et al., 2005) . Furthermore, Xenopus Dlx3 and chick Dlx5 are both necessary and sufficient for Six1 expression (McLarren et al., 2003; Woda et al., 2003) , suggesting that Dlx genes lie upstream of Eya/Six/Dach members in the establishment of the PPR. Because of the inhibitory role of Bmp4 in PPR marker expression, we examined BMP activity in Dlx3b/4b morphants. Although we did not observe changes in bmp4 expression prior to late gastrulation, the domain of bmp4 expression in prechordal mesoderm and tailbud was expanded in Dlx3b/4b morphants beginning at bud stage ( Figure 1C ,D). By midsomitogenesis expression levels returned to those seen in embryos injected with control morpholino ( Figure 1G ,H). To quantify this increase in Bmp4 activity, we performed quantitative RT-PCR on mRNA extracted from bud stage Dlx3b/4b morphants. bmp4 transcripts were detected to be elevated by approximately 40% in bud stage Dlx3b/4b morphants (p<0.005; Supplemental Figure 1 ). We also examined the expression of bmp2b, which is expressed in a pattern similar to bmp4 at the end of gastrulation, and which has been shown to be misregulated in dlx3b/4b morphant embryos (Kaji and Artinger, 2004) . Consistent with previous observations (Kaji and Artinger, 2004) , bmp2b transcript levels were reduced by approximately 15% in Dlx3b/4b morphants (data not shown).
To determine the effects of bmp4 misregulation in Dlx3b/4b morphants, we labeled embryos with antibodies against phosphorylated (P)SMAD1/5/8, which is activated in response to BMP signaling (Yamamoto and Oelgeschlager, 2004) . We observed an increase in PSMAD1/5/8 localization in the anterior neural plate of Dlx3b/4b morphants ( Figure 1E ,F), indicating that these cells have received and are responding to BMP signaling.
This transient misregulation of Bmp4 activity results in morphological dorsoventral (DV) patterning defects; Dlx3b/4b morphants exhibit an increase in intermediate cell mass of the tail similar to the mildest class of ventralization mutants ( Figure 2B ; Kishimoto et al., 1997; Mullins et al., 1996) . Because the ventralization phenotype of Dlx3b/4b morphants is mild, we wished to demonstrate that loss of Dlx3b/4b can increase the severity of ventralization in a sensitized background. We determined an amount of chordin (chd) morpholino that was sufficient to phenocopy the V1 ventralization phenotype and injected it in combination with dlx3b/4b morpholinos. In Chd/Dlx3b/4b triple morphants, the ventralization phenotype was compounded such that embryos resembled the V2 class of ventralization mutants, with a greater expanse in the tail than seen in Chd or Dlx3b/4b morphants alone ( Figure 2B -D).
To further confirm that BMP activity is increased in Dlx3b/4b morphants we examined chd expression. BMP antagonists expressed on the dorsal side of the embryo, such as chd, are negatively regulated by BMP signaling (reviewed in Kimelman and Szeto, 2006; Yamamoto and Oelgeschlager, 2004) . chd expression was reduced in the anterior neural plate and paraxial mesoderm of bud stage and 6-somite Dlx3b/4b morphants (Supplemental Figure 2B ,F,J), consistent with observed elevated BMP levels.
dlx3b/4b mediate BMP signaling through cv2
Cv2 plays a role throughout embryogenesis predominantly as an antagonist of Bmp4 (Ambrosio et al., 2008; Rentzsch et al., 2006; Serpe et al., 2008; Zhang et al., 2008) . During late gastrulation, cv2 is expressed in a pattern around the neural plate ( Figure 3C -F; Rentzsch et al., 2006) resembling that of dlx3b/4b. Our analysis suggests that this pattern of expression spatially overlaps with dlx3b in preplacodal ectoderm ( Figure 3A,B) , rather than being localized to the underlying mesendoderm as initially suggested (Rentzsch et al., 2006) . Following early somitogenesis, cv2 and dlx3b/4b are expressed in the otic placode and pharyngeal arches, raising the possibility that cv2 lies transcriptionally downstream of Dlx3b/ 4b (Figure 3G-J; Ekker et al., 1992; Rentzsch et al., 2006) . Morpholino-mediated knockdown of Dlx3b/4b resulted in a loss of cv2 expression from the PPR during late gastrulation, as well as in the otic placodes and pharyngeal arches during somitogenesis ( Figure 3E -J). Importantly, cv2 expression was not lost from ventral tissues before the onset of dlx3b/4b expression or tail mesoderm during somitogenesis, where its expression does not overlap with dlx3b/4b (data not shown; Figure 3C ,D,G,H; Rentzsch et al., 2006) .
Because loss of Dlx3b/4b increases BMP activity, we wished to determine the effects of overexpressing dlx3b. To do so, we injected dlx3b mRNA into one-and two-cell embryos. bmp4 expression and PSMAD1/5/8 staining were reduced in embryos ectopically expressing dlx3b mRNA ( Figure 4A -D). We also observed expansion of the hindbrain marker krox20 in these embryos ( Figure 4E ,F), consistent with a dorsalization phenotype Mullins et al., 1996) .
Because cv2 expression is lost from dlx3b/4b-expressing tissues in Dlx3b/4b morphants, we wished to explore whether elevated BMP activity observed in these morphants was due to cv2. To demonstrate that dlx3b activates cv2 expression cell-autonomously, the dlx3b ORF was cloned into pCS2+ and injected into 1-cell embryos. Typically, injection of plasmid DNA leads to mosaic distribution of the DNA in later stage embryos. In these embryos, cv2 was coexpressed in the same cells ectopically expressing dlx3b ( Figure 4G ,H).
Furthermore, embryos ectopically expressing dlx3b or cv2 mRNA were moderately (59%; 67/113 and 34; 49/146, respectively) or severely (41%; 46/113 and 24%; 35/146, respectively) dorsalized ( Figure 4I -K,M,N), resembling C3 and C4 classes of dorsalization, respectively Mullins et al., 1996) . Knockdown of Cv2 was able to rescue the dorsalization phenotype seen in embryos ectopically expressing dlx3b mRNA ( Figure 4L ).
Similarly, chd expression in embryos ectopically expressing a dominant negative form of cv2 mRNA (cv2-N; Rentzsch et al., 2006) resembled that of Dlx3b/4b morphants (Supplemental Figure 2D ,H,L). Co-injection of cv2 mRNA with dlx3b/4b morpholinos was sufficient to rescue chd expression (Supplemental Figure 2C ,G,K), demonstrating that the modulation of BMP activity by dlx3b/4b depends at least in part on cv2.
dlx3b/4b-mediated expression of cv2 is necessary for PPR marker expression
Because we observed an increase in BMP activity and a loss of cv2 expression from the PPR of Dlx3b/4b morphants, we wished to determine how disruption of Dlx3b/4b or Cv2 affects PPR formation. BMP activity, particularly Bmp4, inhibits the expression of PPR markers from the Six/Eya/Dach transcriptional network (reviewed in Bailey and Streit, 2006; Brugmann and Moody, 2005; Schlosser, 2006) . Expression of the PPR markers eya1 and six4.1 is lost from the PPR of bud stage Dlx3b/4b and Cv2 morphant embryos ( Figure 5A -C,F-H,). PPR marker expression was restored either when Bmp4 was knocked down or when cv2 mRNA was ectopically expressed in Dlx3b/4b morphants ( Figure 5D ,E,I,J). Although the width of the PPR was not significantly altered in these embryos, we did observe ectopic expression of both eya1 and six4.1 within the neural plate.
Studies in Xenopus have demonstrated that Dlx3 is required to position the PPR. Inhibition of endogenous Dlx activity expands the neural plate at the expense of the PPR (Woda et al., 2003) . To determine whether dlx3b was sufficient to induce ectopic PPR marker expression, we injected the pcs2∷dlx3b DNA construct into one-cell embryos. Under these conditions ectopic dlx3b was sufficient to induce ectopic expression of both eya1 and six4.1 ( Figure 5K , data not shown). Because we were able to rescue the PPR phenotype of Dlx3b/4b morphants by supplying cv2 mRNA, we wished to determine the effects of ectopic cv2 on PPR formation, independent of dlx3b. Injection of pcs2∷cv2 was sufficient to drive ectopic eya1 or six4.1 expression ( Figure 5L , data not shown). Ectopic PPR marker expression was not observed when pcs2∷dlx3b was co-injected with cv2 morpholino (data not shown), suggesting that the PPR inducing properties of dlx3b require cv2.
A small number of cells that expressed either ectopic dlx3b or cv2 did not co-express eya1 or six4.1. Although full length Cv2 acts as a BMP antagonist, it is subject to proteolytic cleavage that renders it an agonist of BMP activity (Rentzsch et al., 2006; Zhang et al., 2008) . We reasoned that the processing of Cv2 into a BMP agonist was responsible for the cells not expressing ectopic eya1 or six4.1. As such, we injected a DNA construct containing an uncleavable form of the cv2 ORF, in which the cleavage site of Cv2 is mutated (cv2-CM; Rentzsch et al., 2006) , into one-cell embryos and assayed ectopic PPR marker expression (Rentzsch et al., 2006) . In these embryos, all cells ectopically expressing cv2-CM co-expressed eya1 and six4.1 (Figure 5M , data not shown). These results suggest that Dlx3b/4b establish the PPR through transcriptional regulation of cv2. Furthermore, induction of PPR marker expression requires low levels of BMP activity, particularly Bmp4. This is mediated through the uncleaved form of Cv2, suggesting that in this context cv2 acts as a BMP antagonist.
Cv2 antagonism of BMP activity promotes FGF activity
Establishment of the PPR requires not only the attenuation of BMP activity but FGF activity as well (Ahrens and Schlosser, 2005; Bailey and Streit, 2006; Brugmann and Moody, 2005; Litsiou et al., 2005; Schlosser, 2006) . Since ectopic expression of either dlx3b or cv2 induced expression of both eya1 and six4.1, we wished to examine the effects of dlx3b and cv2 on FGF activity. The expression of genes induced by FGF activity, including erm and spry4 (Fürthauer et al., 2001; Raible and Brand, 2001) , was observed in cells ectopically expressing dlx3b or cv2 ( Figure 6A ,B,D,E). Ectopic fgf receptor1 (fgfr1) expression was also detected in cells ectopically expressing dlx3b or cv2 (Figure 6C ,E). As with PPR marker expression, some cells expressing ectopic cv2 did not express markers indicative of FGF responsiveness. We were able to drive all cells expressing the uncleavable form of cv2 to express markers indicative of FGF competence (Figure 6G-I) .
In addition to the role of FGF signaling in PPR formation, numerous studies have established that Fgf3/8 signaling from the mesendoderm and hindbrain are required for otic placode induction in zebrafish (Leger and Brand, 2002; Liu et al., 2003; Riley, 2003; Riley and Phillips, 2003; Solomon et al., 2004) . The expression of these FGF ligands is unaffected by loss of Dlx3b/4b (Liu et al., 2003; Solomon et al., 2004) . Nonetheless, Dlx3b/4b are required for the proper expression of the FGF target gene pax2a in otic placode induction (Leger and Brand, 2002; Phillips et al., 2001) . Because our results suggested that Dlx3b/4b and Cv2 may affect competence to respond to FGF activity, we examined the expression of erm and the three fgf receptors (fgfr1-3) expressed in the otic placode (Poss et al., 2000; Scholpp et al., 2004; Sleptsova-Friedrich et al., 2001; Thisse et al., 1995) . erm expression was lost from the hindbrain and otic placode of Dlx3b/4b morphants at the 6-somite stage ( Figure 7A,B ). We observed decreases in fgfr1-3 expression in the otic placode as well as in the hindbrain of Dlx3b/4b morphants ( Figure 7E ,H,K). fgfr1 transcript, which is localized in rhombomere 3 of the hindbrain, otic placode, and MHB, was lost from both rhombomere 3 and the otic placodes of Dlx3b/4b morphants ( Figure 7E) . Similarly, fgfr2 expression was lost from rhombomeres 4 and 6 as well as the otic placode in Dlx3b/4b morphants ( Figure 7H ). fgfr3 expression was lost from the hindbrain and otic placode in Dlx3b/4b morphants ( Figure 7K ). Quantification of fgfr transcript levels in Dlx3b/4b morphants revealed that transcripts were reduced by approximately 30% compared to embryos injected with control morpholinos (p<0.005; Supplemental Figure 1 ). The decrease in fgfr expression in Dlx3b/4b morphants is transient; we did not observe a change in erm or fgfr expression until early somitogenesis, after the increase in bmp4 expression (Supplemental Figure 3 ). Like the increase in bmp4 expression, erm and fgfr expression returned to levels comparable to controls by mid-somitogenesis (Supplemental Figure 4) .
To determine whether the addition of cv2 could rescue the decrease in FGF activity seen in Dlx3b/4b morphants, we co-injected cv2 mRNA with dlx3b/4b morpholinos into one-and twocell embryos. Ectopic cv2 expression was sufficient to restore erm expression in the otic placode and hindbrain of Dlx3b/4b morphants ( Figure 7C ). Likewise, fgfr1-3 expression returned to otic and hindbrain domains in Dlx3b/4b morphants ( Figure 7F ,I,L). Taken together, these results suggest that through their regulation of the BMP antagonist cv2, Dlx3b/4b indirectly promote competence to respond to FGF signaling.
Inhibition of BMP activity can rescue the otic phenotype of Dlx3b/4b morphants
Previous studies have shown that pax2a expression is delayed in the otic placode of Dlx3b/4b morphants until mid-somitogenesis stages (Liu et al., 2003; Solomon et al., 2004) , which corresponds with the transient reduction in fgfr expression we observe in these morphants. As we observed rescue of erm expression when cv2 mRNA was co-injected with dlx3b/4b morpholinos, we wished to determine if ectopic cv2 mRNA was sufficient to rescue pax2a expression in Dlx3b/4b morphants. While we observed variability in the width of the midbrainhindbrain boundary (MHB) and optic stalk of Cv2 morphants consistent with mild DV patterning defects (Rentzsch et al., 2006) , pax2a expression was consistently absent from the otic placode ( Figure 8B-D) . Injection of cv2 mRNA at levels that did not significantly affect DV patterning was sufficient to rescue pax2a expression in the otic placode ( Figure 8E ).
Despite its inhibition of PPR induction, the role of BMP activity in otic placode development has not been examined (reviewed in Ohyama et al., 2007; Riley, 2003) . To examine the effects of elevated BMP activity levels on otic development, we inactivated Dlx3b/4b and Chd in concert. In Dlx3b/4b/Chd triple morphants the expression of eya1, pax2a, and tbx2b was lost from the otic vesicle yet maintained in surrounding tissues (Figure 2E-M) . Therefore, we determined further how manipulation of Cv2 and BMP activity affects otic development in a Dlx3b/4b morphant background. Dlx3b/4b morphants develop an otic vesicle that is reduced in size and lacks otoliths ( Figure 9A,B) (Liu et al., 2003; Solomon and Fritz, 2002) . Although slightly larger, the otic vesicle of Cv2 morphants resembled that of Dlx3b/4b morphants ( Figure  9C ). The otic phenotype of Cv2/Dlx3b/4b triple morphants was no more severe than Dlx3b/ 4b morphants ( Figure 9D ). Furthermore, the otic phenotype of Dlx3b/4b morphants was rescued when cv2 mRNA was co-injected with dlx3b/4b morpholinos ( Figure 9E,F) .
To demonstrate that the otic phenotype of Dlx3b/4b morphants is due to the loss of BMP antagonizing activity of Cv2, we took advantage of a transgenic zebrafish line carrying a truncated form of a type I BMP receptor under the control of a heatshock promoter (abbreviated tBR; Pyati et al., 2005) . In order to attenuate BMP signaling over the stages at which we observed increased BMP activity in Dlx3b/4b morphants, we heat-shocked tBR embryos at bud stage. Attenuating BMP activity in Dlx3b/4b morphants was sufficient to rescue the otic phenotype of Dlx3b/4b morphants Figure 9G ,H). A similar rescue was observed when Bmp4 was knocked down in concert with Dlx3b/4b Figure 9I ,J). This suggests that elevated BMP activity inhibits otic placode induction, and that a major role of Dlx3b/4b is to modulate BMP activity levels in the otic placode, primarily through regulation of cv2 expression.
Because we observed a depression of FGF activity in Dlx3b/4b morphant embryos, we tested whether the Dlx3b/4b morphant phenotype could be rescued by supplying fgfr mRNA to Dlx3b/4b morphants. To do so, we overexpressed fgfr1, the Fgf receptor responsible for mediating Fgf8 signaling (Scholpp et al., 2004) . Injection of fgfr1 mRNA was also able to partially rescue the Dlx3b/4b morphant phenotype (81%; 104/129); the otic vesicle in these embryos was larger and contained one otolith ( Figure 9K,L) . Taken together, these results suggest that BMP activity in the otic placode inhibits the ability of preotic cells to respond to FGF signaling, and that this inhibition occurs at the level of fgfr expression.
Discussion
Numerous studies have shown that placodal precursor cells are derived from a molecularly and embryologically distinct domain, the PPR (Bhattacharyya et al., 2004; David et al., 2001; Ekker et al., 1992; Kobayashi et al., 2000; Kozlowski et al., 1997; Sahly et al., 1999; Streit, 2002; Whitlock and Westerfield, 2000) . PPR formation is a complex process that requires the interplay of several signaling pathways, notably high levels of FGF and low levels of BMP activity (Ahrens and Schlosser, 2005; Brugmann et al., 2004; Glavic et al., 2004; Litsiou et al., 2005) . To understand the development of sensory placodes, it is crucial to determine how the PPR is generated.
Members of the Dlx gene family are expressed in the PPR, raising the possibility that they mediate signaling events to levels conducive for further sensory placode development. In zebrafish dlx3/4b are required for at least otic and olfactory placode development, and in Xenopus Dlx3 is required for the induction of Six1 in the PPR (Solomon and Fritz, 2002; Woda et al., 2003) , suggesting that Dlx genes play a central role in placodal competence (Hans et al., 2007; Hans et al., 2004) . In this context, we have reexamined the role of dlx3b/4b in both the establishment of the PPR and otic placode induction.
Modulation of BMP activity by dlx3b/4b at the neural plate border
Here we show that dlx3b/4b are both necessary and sufficient for the expression of cv2 in the PPR and developing otic placode. Loss of Dlx3b/4b function leads to a transient increase in Bmp4 activity at the end of gastrulation and early somite stages. Introduction of cv2 mRNA or inhibition of Bmp4 or total BMP activity can rescue the PPR and otic phenotypes observed in Dlx3b/4b morphants, demonstrating that Dlx3b/4b mediate BMP activity in the PPR. In the context of PPR specification and otic induction, Dlx3b/4b appear to act as permissive factors, allowing the expression of Eya/Six/Dach gene members in the PPR and pax2a in the otic placode without any direct transcriptional requirement.
In addition to their role in PPR formation, dlx3b/4b likely have other functions at the neural plate border. Our analysis shows that increased BMP signaling is not limited to dlx3b/4bexpressing cells as Dlx3b/4b morphant embryos are mildly ventralized in the tail region. Furthermore, studies by Artinger and colleagues have demonstrated that Dlx-expressing cells at the neural plate border in Xenpus and zebrafish affect neighboring cells in the lateral neural plate domain (Kaji and Artinger, 2004; Woda et al., 2003) . The secretion of Cv2 from the PPR posits a likely mechanism of how Dlx genes can autonomously establish the PPR while exerting non-autonomous influence over the adjacent neural crest/Rohon-Beard domain. Recent studies in Drosophila and Xenopus have shown that Cv2 preferentially binds Bmp4 (and Dpp in Drosohpila) , and that its pro-or anti-BMP effects occur in a dose-dependent manner (Ambrosio et al., 2008; Serpe et al., 2008) , such that high Cv2 levels inhibit Bmp4 ligandreceptor interactions, while low Cv2 levels stabilize them. Furthermore, due to interactions of Cv2 with heparin sulfate proteoglycans, these activities occur over a very short distance from the secreted cell (Rentzsch et al., 2006; Serpe et al., 2008) , potentially explaining why ectopic PPR marker expression is not observed at any distance from cv2-expressing cells. This evidence supports our model in which high levels of Cv2 secreted by dlx3b/4b-expressing cells establishes the presumptive PPR by inhibiting Bmp4 signaling, and may explain how Cv2 enhances the Bmp4 requirements in neural crest and Rohon-Beard cells (Rossi et al., 2008) . However, due to the recently revealed complexities that govern Cv2 function in BMP modulation (Ambrosio et al., 2008; Bier, 2008; Serpe et al., 2008; Zhang et al., 2008) , this latter point remains to be investigated.
Integration of BMP and FGF signaling in PPR and placode formation
In both Xenopus and chick, FGF activity is required but not sufficient for the establishment of preplacodal territory (reviewed in Bailey and Streit, 2006; Schlosser, 2006) . The combination of elevated levels of FGF activity and low levels of BMP activity, however, does appear to be able to induce the full range of PPR markers. Six4, which cannot be induced with ectopic Fgf8 activity alone, can be induced when BMP activity is inhibited in the presence of ectopic Fgf8 (Litsiou et al., 2005) . Similarly in Xenopus, Fgf8 can induce Six1 expression only in the presence of the BMP antagonist Noggin (Ahrens and Schlosser, 2005) . Together, these studies show that induction of the PPR requires a precise balance of high FGF activity and low BMP activity that is normally found at the border of the neural plate.
Despite these studies, it has remained unclear why PPR formation or otic placode induction require attenuation of BMP signaling. Although it is possible that BMP signaling is detrimental to the formation of these tissues per se, our evidence suggests that excessive BMP activity interferes with FGF signaling. Cells ectopically expressing dlx3b or cv2 co-express markers indicative of PPR formation. Many of these cells also express fgfr1 and the FGF feedback regulators erm and spry4, demonstrating Dlx3b/4b and Cv2 confer competence to respond to FGF signaling. This appears to be through the BMP antagonizing activity of Cv2, as all cells ectopically expressing cv2-CM co-express fgfr1, erm and spry4. BMP signaling has similar effects in otic placode induction, where fgfr1-3 expression is reduced in the otic placode and hindbrain of Dlx3b/4b morphants. Interestingly, we were able to significantly rescue both the PPR (data not shown) and otic vesicle defects seen in Dlx3b/4b morphants by overexpressing fgfr1. fgfr1 has previously been shown to mediate Fgf8 signaling, a key component of otic placode induction (Leger and Brand, 2002; Phillips et al., 2001; Riley, 2003; Scholpp et al., 2004) .
Interactions between BMP and FGF signaling pathways have been previously demonstrated. FGF signaling has been shown to interfere with BMP signaling by phosphorylation of the linker region of SMAD1 (Pera et al., 2003) . Conversely, in murine limb bud development, BMP activity inhibits FGF signaling by downregulating Fgf4 expression in the apical ectodermal ridge (Ganan et al., 1996; Pizette and Niswander, 1999; Zuniga et al., 1999) . Our data suggest that in the context of PPR and otic placode induction, BMP activity leads to a downregulation of fgfr expression. This effect may be mediated by BMP targets such as the vent/vox transcriptional repressors (Imai et al., 2001; Melby et al., 2000; Shimizu et al., 2002) ; however, this remains to be elucidated. Thus, we propose that the balance of FGF and BMP activities at the neural plate border is established by in part by Dlx3b/4b through the transcriptional regulation of cv2. Our data suggest that Cv2 acts in its uncleaved, antagonistic form, and dlx3/4b acts to locally establish an environment of low BMP activity. Through the inhibition of BMP activity, Cv2 establishes a region favorable for FGF activity. While it has been suggested that BMP antagonists secreted from underlying mesendoderm act to regulate PPR fate (Litsiou et al., 2005) , Cv2 is the first identified BMP antagonist expressed in the PPR itself that is required for the establishment of this tissue.
Although low BMP activity levels are critical for PPR formation at the end of gastrulation, the initial establishment of dlx3b/4b expression requires BMP signaling. Fate-mapping studies have shown that cells that will become the PPR originate from regions of the gastrula that are initially exposed to higher levels of BMP activity than those cells that will give rise to neural plate (Kozlowski et al., 1997) . These differences in BMP exposure of presumptive PPR and neural ectoderm are reflected by expression of Dlx, Foxi, and Msx family members within presumptive PPR (Feledy et al., 1999; Luo et al., 2001; Matsuo-Takasaki et al., 2005; Nguyen et al., 1998; Pera et al., 1999; Phillips et al., 2006; Suzuki et al., 1997) . BMP signaling directly regulates murine Dlx3 expression through SMAD1 (Park and Morasso, 2002) . Similarly, it has been demonstrated that Dlx3/5/6 expression around chick and Xenopus neural plate are increased in response to elevated BMP activity levels (Feledy et al., 1999; Luo et al., 2001; Pera et al., 1999) . In zebrafish swirl (bmp2b), snailhouse (bmp7), or somitabun (smad5) mutants, dlx3b is not expressed in the PPR or otic placode (data not shown; Nguyen et al., 1998) . Thus, formation of the PPR first requires BMP signaling during early gastrulation to establish a domain of Dlx expression, which subsequently antagonizes BMP activity to levels favorable for induction of the PPR.
Dlx and Cv2: evolutionary implications for PPR establishment
In chick and mouse, Cv2 is expressed in premigratory NC (Coffinier et al., 2002; Coles et al., 2004) , a tissue that requires intermediate levels of BMP activity, while cv2 expression in zebrafish overlaps with dlx3b in preplacodal ectoderm, a tissue that requires low levels of BMP activity (reviewed in Aybar and Mayor, 2002; Bailey and Streit, 2006; Schlosser, 2006) . Furthermore, Cv2 appears to act as an agonist of BMP signaling in chick NC development (Coles et al., 2004) . Although Cv2 expression in chick has not been determined at the relevant stages, it is difficult to reconcile the known Cv2 expression and function in chick with our results in PPR formation. In mouse, Cv2 does not appear to be expressed in the PPR at the onset of somite stages (Coffinier et al., 2002) . While Cv2 expression needs to be more thoroughly examined in amniotes, it is clear that Cv2 expression patterns have diverged between amniotes and zebrafish as there is no expression in zebrafish neural crest.
In amniotes, the Dlx5/6 genes are expressed in a similar manner to zebrafish dlx3b/4b (Ekker et al., 1992; Pera et al., 1999; Yang et al., 1998) . In chick, Dlx5 misexpression leads to upregulation of Six4 (McLarren et al., 2003) , consistent with our observations in zebrafish. However, while the role of Dlx5/6 in PPR formation has not been examined in detail in chick or mouse, knock-out of mouse Dlx5/6 does not appear to affect the induction of the otic placode (Acampora et al., 1999; Merlo et al., 2002; Robledo and Lufkin, 2006; Robledo et al., 2002) . Instead, mutant mice develop later defects in inner ear morphology. The role of the zebrafish dlx3b/4b genes in PPR establishment appears to remain conserved between Xenopus and zebrafish. While the Xenopus Cv2 gene has been identified, its expression has not yet been analyzed (Coles et al., 2004; Moser et al., 2003) . However, as discussed above, Xenopus Dlx3 is required for expression of PPR markers in transplantation experiments, and Dlx3 in Xenopus appears to have similar effects on the lateral neural plate as seen in zebrafish (Kaji and Artinger, 2004; Woda et al., 2003) . Therefore, it is likely that at least in fish and amphibians the role of these genes is similar.
Based on our analysis, we suggest that the discrepancy in the early role of the Dlx genes between mouse and zebrafish in PPR establishment and placode induction might be due to differences in Cv2 expression. Thus, the Dlx5/6 genes are unlikely to play a role in modulation of BMP signaling and establishment of the PPR and seem to be principally involved in later aspects of placode development. Importantly, even though the precise molecular mechanism of PPR induction may show species specific differences, the overall requirements for high levels of FGF activity and attenuated BMP activity appear to be the same in chick, amphibians, and fish (Ahrens and Schlosser, 2005; Brugmann et al., 2004; Glavic et al., 2004; Litsiou et al., 2005) . Evidence from tissue culture in chick supports a model whereby BMP antagonists secreted from mesoderm underlying the PPR are required to position the PPR (Litsiou et al., 2005) , although specific signaling antagonists that act to position the PPR have not yet been identified in vivo in chick or mouse. While our data do not exclude a role of the underlying mesendoderm in fish, we show that a key component in the attenuation of BMP signaling, cv2, is indeed expressed in the PPR itself.
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